AVGO vs STRO · P/E 87, rev $41.50B vs rev $62.0M
Broadcom Inc (AVGO) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Broadcom Inc (AVGO) is a semiconductors company listed on US. It is led by Hock Tan.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported AVGO revenue for 2026-05-03 was $41.50B. Net income was $16.66B. AVGO currently screens at market cap $2.12T and trailing P/E 86.9.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
AVGO currently screens at market cap $2.12T and trailing P/E 86.9. STRO currently screens at market cap $470.8M.
Not investment advice. Open the AVGO and STRO stock pages for the full models.
Not investment advice.